EC

Edward Carr

DELAYED 1 MONTH

CHIEF ACCOUNTING OFFICER

Dianthus Therapeutics, Inc. /DE/

Filings

1

Companies

1

Latest

Mar 12, 2026

Transactions

Signal

Ticker / Company

Insider

Transaction

Value

Filed

80
DNTHCLUSTER 3FULL EXIT

Dianthus Therapeutics, Inc. /DE/

Edward Carr

CHIEF ACCOUNTING OFFICER

Sale

$3.6M

43,682 sh

Mar 14 12:30 AM

Mar 12, 2026

—

Dianthus Therapeutics, Inc. /DE/

Edward Carr

CHIEF ACCOUNTING OFFICER

Option Exercise

$893.3K

43,682 sh

Mar 14 12:30 AM

Mar 12, 2026